Malika Ammam, PhD,  —

Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She has also held the prestigious Rosalind Franklin fellowship.

Articles by Malika Ammam

Mitochondria, with Key Role in Neurodegeneration, May Offer Therapy Target, Review Suggests

Mitochondria play key roles in the processes that can lead to neurodegeneration and diseases like Alzheimer’s or Parkinson’s, a review of published studies into mitochondria-associated neurodegeneration found. The review also suggested that mitochondria are a therapeutic target worth investigating. Details of these findings, “Mitochondrial Dysfunction and Biogenesis in Neurodegenerative…

Scientists Develop New Peptides as Novel Therapies for Mitochondrial Diseases

A study led by researchers at Washington University School of Medicine and Albert Einstein College of Medicine found a new route to correct dysfunctional mitochondria. The scientists designed small compounds that could help treat Charcot-Marie-Tooth disease (CTMD) and other mitochondrial diseases. The study, “Correcting mitochondrial fusion by manipulating mitofusin conformations,” was recently published…

Modified Atkins Diet Can Cause Muscle Damage in People with Mitochondrial Myopathy, Study Finds

A Finnish study of a modified Atkins diet, a popular high‐fat/low‐carbohydrate diet, in a small group of people with mitochondrial myopathy (MM) and progressive external ophthalmoplegia (PEO) found the diet induced progressive muscle pain and damage within two weeks, and the researchers suggest that patients using such diets to control disease symptoms be closely monitored.